47 results on '"Göhring, G"'
Search Results
2. Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis
3. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
4. Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
5. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants
6. Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004
7. Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate
8. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
9. Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q
10. Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
11. The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
12. Analysis of NUP98/NSD1 translocations in adult AML and MDS patients
13. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
14. Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide
15. Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia
16. Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice
17. ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia
18. Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone
19. Low frequency of calreticulin mutations in MDS patients
20. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes
21. Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide
22. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
23. A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
24. Global increase in DNA methylation in patients with myelodysplastic syndrome
25. Familial polycythemia vera with non-germ line JAK2V617F mutation sparing the abnormal and clonal granulopoiesis
26. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome
27. The MLL recombinome of acute leukemias in 2017
28. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
29. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants
30. The MLL recombinome of acute leukemias in 2017
31. The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
32. Analysis of NUP98/NSD1 translocations in adult AML and MDS patients
33. Incidence and prognostic impact of ASXL2mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group
34. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
35. Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide
36. Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia
37. Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide
38. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes
39. Clinical impact of GATA2mutations in acute myeloid leukemia patients harboring CEBPAmutations: a study of the AML study group
40. The MLL recombinome of acute leukemias in 2017
41. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
42. "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
43. A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
44. IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.
45. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
46. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
47. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.